Kirkland & Ellis is advising R1 RCM, Skadden is advising a special committee of the R1 RCM Inc. in the transaction, while Wachtell, Lipton, Rosen &...
TowerBrook and CD&R’s $8.9 Billion Acquisition R1 RCM
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
Novartis’ Acquisition of MorphoSys
Skadden advised MorphoSys AG in the deal. MorphoSys AG has entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG (hereinafter collectively referred...
The RMR Group’s Acquisition of CARROLL Multifamily Platform
Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal advisor to RMR, while King & Spalding LLP is acting as legal advisor to CARROLL....
GSK’s Acquisition of BELLUS Health
Paul, Weiss, Rifkind, Wharton & Garrison LLP, and Stikeman Elliott LLP advised GSK, while Skadden, Arps, Slate, Meagher & Flom LLP, and Davies Ward Phillips &...
ABP Acquisition’s $43.8 Million Acquisition of AlerisLife
Skadden advised ABP Acquisition on the deal. AlerisLife Inc. (“ALR”) has entered into a definitive agreement with ABP Acquisition LLC under which ABP will acquire all...
Alcon’s Acquisition of Aerie Pharmaceuticals
Skadden, Arps, Slate, Meagher & Flom represented Alcon, while Fried, Frank, Harris, Shriver & Jacobson represented Aerie in the transaction. Alcon entered into a definitive merger...
Vertex’s $320 Million Acquisition of ViaCyte
Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
Halozyme Therapeutics’ Acquisition of Antares Pharma
Weil, Gotshal & Manges advised Halozyme, while Skadden, Arps, Slate, Meagher & Flom advised Antares Pharma on the deal. Fried Frank acted as counsel to BofA...
CSC’s Acquisition of Intertrust
Skadden, Arps, Slate, Meagher & Flom LLP and Houthoff Coöperatief U.A. advised CSC on the deal. De Brauw advised Intertrust. CSC, the world’s leading provider of...
MorphoSys’ $1.7 Billion Acquisition of Constellation Pharmaceuticals
Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...
Alcon’s Acquisition of U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Skadden, Arps, Slate, Meagher & Flom LLP advised Alcon on the deal. Alcon, the global leader in eye care dedicated to helping people see brilliantly, has...